Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Summit Therapeutics (SMMT) Interest & Investment Income: 2013-2019

Historic Interest & Investment Income for Summit Therapeutics (SMMT) over the last 7 years, with Dec 2019 value amounting to $5,000.

  • Summit Therapeutics' Interest & Investment Income fell 138.41% to -$1,000 in Q1 2020 from the same period last year, while for Mar 2020 it was $3.7 million, marking a year-over-year decrease of 0.06%. This contributed to the annual value of $5,000 for FY2019, which is N/A change from last year.
  • According to the latest figures from FY2019, Summit Therapeutics' Interest & Investment Income is $5,000, which was up 100.14% from -$3.7 million recorded in FY2019.
  • Summit Therapeutics' Interest & Investment Income's 5-year high stood at $5,000 during FY2019, with a 5-year trough of -$4.4 million in FY2018.
  • In the last 3 years, Summit Therapeutics' Interest & Investment Income had a median value of -$1.8 million in 2017 and averaged -$2.0 million.
  • Per our database at Business Quant, Summit Therapeutics' Interest & Investment Income plummeted by 545,378.08% in 2015 and then skyrocketed by 76.19% in 2017.
  • Summit Therapeutics' Interest & Investment Income (Yearly) stood at -$77,000 in 2015, then surged by 45.45% to -$42,000 in 2016, then soared by 76.19% to -$10,000 in 2017, then slumped by 43,830.00% to -$4.4 million in 2018, then rose by 16.64% to -$3.7 million in 2019, then reached $5,000 in 2019.